Source:http://linkedlifedata.com/resource/pubmed/id/19245590
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2009-2-27
|
pubmed:abstractText |
This study examines whether the expression of cyclooxgenase-2 (COX-2) in urothelial carcinoma (UC) is associated with macrophage infiltration, hypoxia-inducible factor-1alpha (HIF-1alpha) expression and angiogenesis. We investigated the expression of COX-2 associated with HIF-1alpha and performed double immunohistochemical analysis of 216 UCs for COX-2 expression and the correlation with tumor-associated-macrophage (TAM) density and microvessel density (MVD) in situ. A high expression of COX-2 was positively correlated with tumor invasiveness, histologic grade and HIF-1alpha expression in UC (p<0.0001, p=0.003, p<0.0001, respectively). Quantification of double staining of COX-2/CD34 and COX-2/CD68 showed that a higher MVD and TAM density was found in COX-2 high-expression than in COX-2 low-expression tumor fields (p<0.0001). Adjacent to the principal of COX-2 expression areas, MVD value and TAM density were significantly increased in HIF-1alpha high-expression specimens compared with HIF-1alpha low-expression ones (p<0.0001). Interestingly, our data revealed that high COX-2 expression (p=0.002), high HIF-1alpha expression (p<0.0001) and TAM density (p<0.0001) were all associated with high MVD value. Our results suggest that COX-2 may produce a cooperative effect in promoting tumor progression and may be involved in the process of angiogenesis through increasing TAM infiltration or HIF-1alpha regulation by hypoxia.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
1600-0463
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
117
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
176-84
|
pubmed:meshHeading |
pubmed-meshheading:19245590-Aged,
pubmed-meshheading:19245590-Carcinoma,
pubmed-meshheading:19245590-Cyclooxygenase 2,
pubmed-meshheading:19245590-Female,
pubmed-meshheading:19245590-Humans,
pubmed-meshheading:19245590-Hypoxia-Inducible Factor 1, alpha Subunit,
pubmed-meshheading:19245590-Immunohistochemistry,
pubmed-meshheading:19245590-Kidney Neoplasms,
pubmed-meshheading:19245590-Macrophages,
pubmed-meshheading:19245590-Male,
pubmed-meshheading:19245590-Neoplasm Invasiveness,
pubmed-meshheading:19245590-Neovascularization, Pathologic,
pubmed-meshheading:19245590-Ureteral Neoplasms,
pubmed-meshheading:19245590-Urinary Bladder Neoplasms,
pubmed-meshheading:19245590-Urologic Neoplasms,
pubmed-meshheading:19245590-Urothelium
|
pubmed:year |
2009
|
pubmed:articleTitle |
Overexpression of cyclooxygenase-2 in urothelial carcinoma in conjunction with tumor-associated-macrophage infiltration, hypoxia-inducible factor-1alpha expression, and tumor angiogenesis.
|
pubmed:affiliation |
Department of Pathology, Kaohsiung Medical University, Chung-Ho Memorial Hospital, No. 100 Tzyou 1st Road, Kaohsiung City, Taiwan.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|